KRAS G12V mutation as an acquired resistance mechanism after treatment with dabrafenib and trametinib in non-small cell lung cancer harbouring the BRAF V600E mutation: a case report

Hajime Oi, Kiyotaka Yoh, Shingo Matsumoto, Hiroki Izumi, Yuji Shibata, Tetsuya Sakai, Kaname Nosaki, Yoshitaka Zenke, Koichi Goto